|
|
|
|
|
|
|
LEO Pharma files IND for AD drug
|
 LEO Pharma has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for the study of an oral atopic dermatitis treatment, JW1601/LP0190, according to a company announcement. |
|
|
|
FDA accepts NDA for acne lotion
|
|
The U.S. Food and Drug Administration (FDA) accepted a new drug application (NDA) for Ortho Dermatologics’ novel tazarotene O.045% lotion (IDP-123) with a PDUFA action date of Dec. 22, 2019, according a recent announcement from the company. |
|
ADVERTISEMENT
|
|
|
|
|
|
|
|
|
|
|
|
Don’t rely on antibiotics for acne
|
|
Curbing use of antibiotics to treat acne has been challenging despite updated guidelines supporting limited use and the growing problem of bacterial resistance. But things seem to be changing for the better, says Diane M. Thiboutot, M.D.
|
|
|
|
|
|
Nature-based skin care for rosacea
|
Burt's Bees skin care products may be an effective as an adjunct to prescription therapy in the management of rosacea, according to data published in the Journal of Drugs in Dermatology.
|
|
|
|
|
|
ADVERTISEMENT
|
|
Earn Complimentary CME/CE Credits |
Review the properties and aesthetic uses of available neuromodulators through a review of the literature, real-world cases, and expert clinical perspectives.
 CLICK HERE to read the About Face monograph.
|
|
|
|
|
|
|
|
|
Pediatric psoriasis
|
|
About one-third of patients with psoriasis are children or adolescents. Still, little research exists on treating this patient population. New disease management guidelines and emerging studies seek to fill the gap.
|
|
|
|
|
|
A patient-centered approach
|
In psoriasis, many therapies offer roughly the same level of care, but that doesn’t mean any patient will respond well to any therapy. According to Mark Lebwohl, M.D., physicians should consider each treatment option in light of a patient's specific comorbidities.
|
|
|
|
|
|
|
|
|
|
Defining AD
|
|
In this video, Dr. Lazzara discusses a study that examined operational definitions of atopic dermatitis in the literature, and their potential effect on prevalence and associated risk factors.
|
|
|
|
|
|
Adult-onset AD
|
Twenty-five percent of adults with atopic dermatitis report the disease started in adulthood. Yet, diagnosing adult-onset atopic dermatitis can challenge even expert clinicians. Here's what you need to know.
|
|
|
|
|
|
|
|
|
|
Melanoma immunotherapy
|
|
Dermatologists should work to gain a better understanding of immunologic pathways as well as the mechanisms of new and evolving immunotherapies, as these are key for understanding many current and emerging melanoma treatments, one expert says.
|
|
|
|
|
|
Lasers aid AK Tx
|
Laser-assisted drug delivery used to fractionally ablate the target area prior to topical medical treatment can be useful in patients with widespread actinic damage, says this expert.
|
|
|
|
|
|
|
|
|
|
Nonsurgical fat reduction
|
|
Nonsurgical fat reduction device choices are taking the market by storm, with technologies that target fat via cryolipolysis, laser lipolysis or radiofrequency.
|
|
|
|
|
|
Skincare advice across generations
|
To meet the skin's changing needs over various life stages, experts at the Generational Dermatology Symposium held earlier this year suggest being proactive about barrier problems and that moisturization is key to maintaining skin health.
|
|
|
|
|
|
ADVERTISEMENT
|
|
Celebrate Greatness – Recognize an Innovator |
Giants of Dermatology™ is a peer-to-peer nomination program that salutes excellence within the dermatology community and honors physicians and industry leaders whose efforts continue to inspire, inform, and advance treatment. Know an individual who deserves to be celebrated?
 Nominate them today!
|
|
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
|
|
|
